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Abstract 
A breast cancer survivor’s journey does not end with treatment. After treatment, most 
breast cancer survivors go on to face many life-long physical and mental challenges caused by 
their cancer and treatment. Once active cancer treatment is completed, patients enter the next 
important step in cancer care, cancer survivorship. Cancer survivorship is a comprehensive 
approach to post-oncology management that promotes the best outcomes for survivors as they 
transition from oncology care to primary care; and new breast-cancer survivorship guidelines 
have emerged. Research suggests that primary care NPs’ lack of awareness of the current 2016 
American Cancer Society/American Society of Clinical Oncology [ACS/ASCO] Breast Cancer 
Survivorship Care Guidelines impedes their ability to provide the best evidence-based care for 
breast cancer survivors. This DNP project was designed to develop a breast cancer survivorship 
toolkit based upon contemporary breast cancer survivorship guidelines as part of the ongoing 
effort to better inform primary care NPs of survivors’ needs and promote best-practices 
implementation. 
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Chapter 1 
Introduction 
Though not realized by many, a breast cancer survivor’s journey does not end with 
treatment. In fact, most breast cancer survivors go on to face many life-long physical and mental 
challenges caused by both their cancer and its treatment. Once active cancer treatment is 
completed, breast cancer patients enter the next important, but often neglected, step in cancer 
care, which is cancer survivorship. Cancer survivorship is a comprehensive approach to post-
oncology management and aims to achieve the best outcomes for breast cancer survivors as they 
transition from oncology care to primary care. In this setting, nurse practitioners (NPs) share in 
the responsibility of providing the highest quality survivorship care for such a vulnerable 
population. While treatment for post-oncology care has long been a part of ongoing health care, 
relatively new breast cancer survivorship care guidelines are emerging. Unfortunately, most NPs 
in primary care remain unaware of these guidelines and implementation methodologies for the 
evidence-based practices to fulfill the unique needs of these patients.  
Cancer survivorship care is an approach to care that addresses the specific ongoing needs 
of cancer survivors (American Society of Clinical Oncology [ASCO], 2013). This care includes 
prevention and surveillance for new or recurrent cancers, management of late and long-term 
disease and treatment effects, and health promotion and coordination between healthcare 
specialties when appropriate (ASCO, 2013). In recent years, primary care providers (PCPs) have 
been designated the key providers of cancer survivorship care (Sun, Olausson, Fujinami, Chong, 
Dunham, Tittlefitz, ... & Grant, 2015). PCPs can be physicians, physician’s assistants (PAs), and 
NPs working within the primary care setting. This project was designed for NP primary care 
providers managing female breast cancer survivors.   
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Phenomenon of Interest 
Breast cancer is the most prevalent malignancy among women (ASCO, 2017; Miller, 
Siegel, Lin, Mariotto, Kramer, Rowland, … & Jemal, 2016). Research shows that a woman’s 
lifetime risk of being diagnosed with breast cancer has increased within the last 40 years from 1 
in 11 women to 1 in 8 women (American Cancer Society [ACS], 2017). According to the ACS 
(2017), the increased prevalence of breast cancer is a result of increased life expectancy, changes 
in reproductive patterns, increased obesity prevalence, use of menopausal hormones, and a rise in 
improved screening and early detection. Although the incidence of breast cancer has risen, the 
past 20 years have been characterized by a simultaneous decline in breast cancer mortality 
(Miller et al., 2016). 
There are several factors that have contributed to the decrease in breast cancer mortality 
rate even in the face of its increasing prevalence. Most notably, significant advances in cancer 
research and effective treatment options have improved breast cancer patients’ survival rate 
(Pandey & Nguyen, 2017). Further, advances in early detection methods and preventative 
measures have improved long-term life expectancy (Miller et al., 2016). As a result, the breast 
cancer survivor population is steadily increasing with an average five-year survival rate of 90% 
(ACS, 2017). This significant increase in the number of breast cancer survivors calls for a greater 
need for improved cancer survivorship care. 
  In response to the growing breast cancer survivor population, multiple cancer 
organizations and researchers have explored best practices for survivorship care and potential 
barriers to its application. Research shows that breast cancer patients experience a better quality 
of life when receiving cancer survivorship care; however, research has also demonstrated that the 
majority of primary care NPs are ill-prepared to provide such care (American Cancer 
Society/American Society of Clinical Oncology [ACS/ASCO], 2016; Koch, Jansen, 
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Herrman,…& Arndt, 2013; Pandey & Nguyen, 2017; Pandey & Barber, 2016). Pandey and 
Nguyen (2017) suggest that this lack of preparation stems from the NPs’ minimal education and 
training specific to cancer survivors’ follow-up needs and late and long-term cancer and 
treatment effects. As a result, breast cancer survivors’ unique physical and emotional needs are 
often neglected in the transition from the oncologist to the primary care NP (Pandey & Nguyen, 
2017). While breast cancer survivorship care guidelines and recommendations have been created 
to close the knowledge gap, there have been few study results indicating improvement in practice 
(ACS/ASCO, 2016; Pandey & Nguyen, 2017; Pandey & Barber, 2016; Sun et al., 2015). 
Luctkar-Flude et al. (2015) conducted a breast cancer guideline implementation study that 
showed that only 46.4% of breast cancer survivorship care guidelines were being implemented 
“half the time” by 82 participating PCPs. The study concluded that limited provider knowledge 
of the survivorship care guidelines in primary care was a leading contributor to minimal 
implementation (Luctkar-Flude et al., 2015). By bringing cancer survivorship care guidelines 
into practice and increasing primary care NPs' knowledge of these guidelines, NPs can more 
proficiently address breast cancer survivor needs and ultimately improve patient outcomes.  
Problem Statement   
 Primary care NPs’ lack of awareness of the current 2016 ACS/ASCO Breast Cancer 
Survivorship Care Guidelines, impedes their ability to provide the best evidence-based care for 
breast cancer survivors. This lack of awareness creates inconsistencies in follow-up, screening, 
management of late and long-term disease and treatment effects, and health promotion for 
patients transitioning from oncology to primary care. Addressing the lack of awareness and 
resultant inconsistencies can ultimately improve the quality of life of breast cancer survivors by 
more fully managing cancer and treatment related side effects, minimizing inappropriate 
screening and subsequent allocation of resources, and reducing unnecessary oncology referrals 
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(Siu, 2016; Pandey & Nguyen, 2017).  
Purpose Statement 
The purpose of this DNP project is to create a professional development project (PDP) to 
better inform primary care NPs of female breast cancer survivors’ needs and the current breast 
cancer survivorship care guidelines to improve patient outcomes. The PDP includes a 
PowerPoint® presentation and a breast cancer survivorship Toolkit (“Toolkit”) that was created 
based on the 2016 ASC/ASCO Breast Cancer Survivorship Care Guidelines. This project aims to 
help primary care NPs provide evidence-based care to breast cancer survivors throughout all 
stages of their post-oncology journey. 
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Chapter 2 
Review of the Literature 
Breast Cancer  
  Cancer is a significant health problem affecting homes and communities worldwide. It is 
the second leading cause of death in the United States (Siegel, Miller, & Jemal, 2018). Among 
women, breast cancer is the most prevalent malignancy. According to the ACS (2018), an 
estimated 266,120 new cases of female breast cancer will be diagnosed in 2018, comprising 30% 
of all cancers that will be diagnosed in women (Siegel, Miller, & Jemal, 2018). As such, 
awareness of breast cancer risk factors, screening, treatment(s), late and long-term side effects, 
and survivors’ needs is imperative.  
Risk Factors 
Numerous risk factors have led to the increased prevalence of breast cancer. First, 
improved mammography techniques have caused an influx of breast cancer diagnoses over the 
last 20 years (ACS, 2017). Since the1980s, in situ and invasive breast cancer incident rates have 
continuously fluctuated with an overall steady increase in recent years. On average today, 
women are being diagnosed 1 to 3 years earlier than in the past due to improved technology 
(ACS, 2017). Second, changes in women’s reproductive patterns have also been confirmed as a 
breast cancer risk factor. Such changes include women increasingly delaying childbearing, 
having their first child after age 35, and having fewer number of children born per woman over 
the past 40 years (ACS, 2017).  
Third, experts have found a strong correlation between breast cancer and obesity. Obesity 
has been an especially significant risk factor in postmenopausal women. According to the ACS 
(2017), an overweight premenopausal woman’s breast cancer risk is one and a half times greater 
for developing breast cancer than that of their lean counterpart. However, an overweight 
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postmenopausal woman’s risk is two times greater compared to her lean counterpart. Experts 
believe that this increased risk is the result of increased estrogen levels in the fatty tissue and 
higher incidences of type 2 diabetes within this population (ACS, 2017). Fourth, women’s 
sustained use of menopausal hormone therapy, and particularly combined estrogen and progestin 
menopausal hormones, contributes to about one-third of postmenopausal breast cancer. Finally, a 
woman’s risk for breast cancer is affected by her strong personal and family history of breast 
cancer. A first-degree relative, such as a mother with a history of breast cancer, increases that 
woman's risk of being diagnosed two times more than a woman with no family history (ACS, 
2017). This risk increases by four times more if two or more first-degree relatives have a history 
of breast cancer. In such cases, BRCA1 and BRCA2 inherited gene mutations should be 
considered as they increase a woman’s risk of breast cancer by up to 10% (ACS, 2017). 
Screening  
Women with average breast cancer risk, minimal risk factors, and no pre-existing cancer 
history should have annual mammograms from the age of 45 to 54 (ACS/ASCO, 2016). High 
risk women with multiple non-modifiable risk factors, however, can start annual mammograms 
as early as 40 years old. Between the ages of 55 to 74, all women should receive biennial 
mammograms. Those women with a history of normal mammogram results have the option of 
discontinuing biennial screening after age 75. High-risk patients with a personal history of breast 
cancer should receive annual mammograms as routine screening for recurrence of cancer. This 
excludes screening of reconstructed breast(s) after mastectomy (ACS/ASCO, 2016). Women 
with a family history of breast cancer from a first-degree relative or those who have inherited the 
BRCA mutation should begin screening at age 25 or about five to 10 years earlier than the 
earliest age that breast cancer was diagnosed in the family (Tirona, 2013). MRI screening is not 
recommended for these women, unless cancer is suspected based on symptoms or abnormal 
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mammogram results. As of 2013, experts do not recommend breast self-examinations, as 
temporary changes may occur in breast tissue with normal hormone level changes. However, 
women should be familiar with the normal feel and appearance of their breasts and should report 
any prolonged or worsening changes (Tirona, 2013).   
Treatments 
There are several treatments for breast cancer. Treatment modalities include surgery, 
chemotherapy, radiation therapy, hormone or endocrine therapy and targeted therapy 
(ACS/ASCO, 2016). When deciding on the appropriate treatment(s), the patient and her 
oncologist must consider both the cancer's stage and biological characteristics. Additionally, the 
patient’s age, preferences, menopausal state, and potential risks and benefits should be 
considered when deciding on a treatment plan. Most cases of early-stage breast cancer will 
require a combination of treatments to ensure best patient outcome of reduced risk of recurrence. 
Generally, some form of surgical intervention is performed following use of radiation or 
systemic therapies. Cases involving metastatic disease are primarily treated with systemic 
therapies only. With metastatic disease, surgical intervention is not indicated, and chemotherapy, 
hormone therapy, and targeted therapy are used to help prolong life while balancing quality of 
life (ACS, 2017). 
Surgical interventions for breast cancer involve either breast-conserving surgery (BCS) or 
total mastectomy. BCS, which is a partial mastectomy or lumpectomy, is only recommended for 
early-stage breast cancer and is not an option for patients with a high tumor-to-breast ratio, 
advanced cancers, or multicentric cancers (ACS, 2017). BCS involves the removal of only the 
cancerous tissue and tumor margin, which is the normal tissue directly surrounding the tumor. 
BCS is regularly followed with radiation therapy that involves the use of high-energy beams to 
kill cancer cells. This treatment combination helps reduce the risk of breast cancer recurrence by 
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up to 50% at 10 years (ACS, 2017). A total mastectomy involves the removal of the entire breast. 
In more advanced cases, a modified radical mastectomy may be recommended if dissection of 
full axillary lymph nodes with the breast is indicated. Radiation therapy may be utilized for 
symptom relief in advanced cases with central nervous system or bone metastases (ACS, 2017). 
Systemic therapy is the leading treatment option for metastatic breast cancer and is 
sometimes used with early-stage breast cancer (ACS, 2017). It includes the use of hormone 
therapy, chemotherapy, and targeted therapy. Each therapy has a different mechanism of action 
and can target different molecular subtypes that are specific to that tumor. These different 
subtypes help determine which systemic treatments will be most effective. For example, the 
presence or absence of hormone receptors on the tumor will dictate whether hormone therapy or 
chemotherapy is more appropriate (ACS, 2017). Hormone-sensitive tumors make up over 70% 
of breast cancers and grow from the stimulation of the body's natural production of estrogen and 
progesterone. Hormone therapy works to block or diminish these hormone levels for those 
tumors that are estrogen receptor positive (ER+) and progesterone receptor positive (PR+). 
Another subtype that accounts for 17% of breast cancers is the “"overproduction of the growth-
promoting protein HER2” (ACS, 2017, p.28). This type of cancer requires the use of targeted 
therapy to specifically attack those molecules involved in active cancer growth. The HER2 
subtype can be found in either hormone-sensitive or insensitive tumors allowing for the 
combination of the targeted therapy medications with hormone therapy or chemotherapy to help 
increase treatment effectiveness. Chemotherapy, which is the use of drugs that are designed to 
attack rapidly growing cells, is most effective in treating hormone-insensitive cancers. They can 
be as a neoadjuvant or adjuvant treatment depending on tumor stage and size. Research shows 
that treatment effectiveness is enhanced when the full dose and recommended number of cycles 
are given with minimal interruptions or delays (ACS, 2017).  
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Survivorship 
Late and Long-Term Effects 
Women who undergo surgery, radiation therapy, and systemic therapies frequently face 
the accompanying undesirable and often lifelong physical and psychological adverse effects. Up 
to 67% of breast cancer survivors report body image concerns following BCS, total mastectomy, 
and radiation therapy (ACS/ASCO, 2016). Contributing physical factors include scarring, 
disfigurement, skin discoloration, radiation-associated fibrosis, and skin laxity. Breast cancer 
survivors report that lymphedema is a significant contributor to body image issues. About 20% 
of patients who undergo axillary lymph node dissection and 6% of patients who receive sentinel 
lymph node biopsies develop lymphedema (ACS, 2017). Additionally, limited range of motion, 
pain, neuropathy, upper extremity weakness, diminished skin sensitivity, sexual dysfunction, 
lung fibrosis, and fatigue are also common potential late and long-term effects associated with 
surgery and radiation.  
Breast cancer survivors who undergo chemotherapy commonly experience hair loss, 
weight gain, infertility, neuropathy, and cognitive impairment (ACS/ASCO, 2016). Late effects 
generally manifest as osteoporosis and cardiovascular disease. Tamoxifen and aromatase 
inhibitors (AIs), the two leading hormone therapies for breast cancer, have notable lasting effects 
among breast cancer survivors. Some of the most commonly reported effects are early 
menopause, joint pain, increased fractures, elevated cholesterol, chronic musculoskeletal pain, 
vaginal dryness, depression, and anxiety (ACS/ASCO, 2016). Furthermore, these treatments 
come with increased risk of stroke, endometrial cancer, blood clots, and cardiac dysfunction 
(ACS/ASCO, 2016). If not addressed, these effects can have negative implications on the quality 
of life among breast cancer survivors, especially younger survivors (ACS/ASCO, 2016).  
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Breast Cancer Survivors 
Breast cancer survivors account for 41% of all female cancer survivors in the United 
States (Westfall, Overholser, Zittleman, & Westfall, 2015). Breast cancer survival has increased 
considerably over the past two decades with a 39% decline in the mortality rate since 1989. This 
improvement is attributed to changes in early screening, advances in technology, and 
improvements in treatment options (ACS, 2017). As of 2016, more than 15.5 million people in 
the United States were cancer survivors. Of that number, more than 3.5 million were female 
breast cancer survivors. This overall number of cancer survivors is projected to increase to over 
20 million by 2026, with female breast cancer survivors making up a significant percentage 
(Miller et al., 2016). The majority of breast cancer survivors are living cancer-free, while others 
are living with evidence of cancer or are currently receiving some form of treatment. This 
accounts for a wide range of unique care needs specific to this population (Siegel, Miller, & 
Jemal, 2018). As a result, greater stress has been placed on the cultivation and education of 
cancer survivorship care within the primary care setting.  
Evolution of Cancer Survivorship Care 
In 2005, the Institute of Medicine (IOM) issued a seminal report, From Cancer Patient to 
Cancer Survivor: Lost in Transition. This report highlighted the need for change in cancer 
survivors' care and recommended specific goals and standards to improve the process (Hewitt, 
Greenfield, & Stovall, 2005). Since the report’s release, components of cancer survivorship care 
and the roles of oncology and primary care have been better defined. The National 
Comprehensive Cancer Network (NCCN) (2017) states that individuals are considered cancer 
survivors from the time of diagnosis until his or her death. Survivorship care is a specific 
standard of care designed to address the multifaceted needs unique to cancer survivors (NCCN, 
2017). Cancer survivorship is recognized as the final phase of the cancer care continuum and is 
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considered the transition to post-treatment care (George Washington University Cancer Institute 
[GWCI], 2013). Fundamental components of survivorship care include prevention of new or 
recurrent cancers, surveillance, assessment and management of physical and psychological 
effects, coordination of care, and health promotion. Combined, these care components help in the 
management of physical, psychological, social, spiritual, and informational needs of cancer 
survivors (NCCN, 2017; GWCI, 2013). 
Research organizations, such as the ACS, NCCN, ASCO, and Centers for Disease 
Control and Prevention (CDC), among others, have contributed to cancer survivorship research, 
survivorship care programs, and cancer-specific practice guidelines to improve the practitioners’ 
ability to care for cancer patients (ACS/ASCO, 2016; NCCN, 2017; GWCI, 2013). This research 
supports the central role primary care NPs have in cancer survivorship care as well as the 
existing knowledge limitations (Pandey & Nguyen, 2017). To address knowledge limitations, the 
ACS and ASCO created current cancer survivorship care guidelines to assist providers in the 
comprehensive care of cancer survivors. This includes the ACS/ASCO’s 2016 Breast Cancer 
Survivorship Care Guidelines, which are specifically designed to help NPs address the needs of 
the growing breast cancer survivor population.  
ACS/ASCO Breast Cancer Survivorship Care Guidelines 
In 2016, the ACS and ASCO released Breast Cancer Survivorship Care Guidelines aimed 
specifically at helping NPs provide evidence-based care to adult female breast cancer survivors. 
The guidelines focus on the ongoing impact that breast cancer diagnosis and treatment(s) have on 
female survivors. Included are specific recommendations for treating survivors after completion 
of their primary treatment and continuing throughout the balance of their life. These specific 
recommendations provide a framework for NPs to follow in addressing breast cancer survivor 
surveillance for recurrence, screening for second primary cancers, assessment and management 
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of physical and psychological late and long-term effects, health promotion, and coordination of 
care (ACS/ASCO, 2016). In addition to these guidelines, NPs should refer to the cancer 
survivor's treatment summary or survivorship care plan if made available by the referring 
oncologist (ACS, 2017).   
Surveillance and Screening 
To increase the chances of a prolonged life, breast cancer survivors must continue 
surveillance and screening after treatment. The survivorship guidelines recommend that NPs 
perform a cancer-related history and physical examination every 3 to 6 months for the first three 
years, then every 6 to 12 months for the next two years after primary therapy (ACS/ASCO, 
2016). After the five-year mark, an annual history and physical is recommended for survivors' 
continued surveillance. Women who received a unilateral mastectomy should have annual 
mammogram screenings of the remaining breast. Bilateral mastectomy does not require routine 
mammograms, but these women should be screened through a detailed annual history and 
physical. Breast cancer survivors with lumpectomies should receive annual mammograms of 
both breasts. MRI screening is not recommended for breast cancer survivors unless they are 
suspected of local recurrence or evidence of a new primary breast cancer. Routine laboratory 
tests for tumor markers and imaging studies (i.e., chest radiograph, CT scans, and bone scans) 
are not recommended in the primary care setting for screening purposes. Additionally, NPs 
should educate breast cancer survivors on relevant signs and symptoms of cancer recurrence. 
Such signs and symptoms include the presence of new lumps in the axillae or neck, skin changes 
over the chest wall or breast, changes in breast contour/size/shape, or prolonged swelling and 
pain in breast or arm (ACS/ASCO, 2016). 
Cancer surveillance also includes the assessment of continuous adherence and symptom 
management of those women being treated with adjuvant antiestrogen therapy. Women with a 
 13 
strong family history of breast cancer should be offered a genetic counseling referral by the NP 
to better assess risk factors. Additionally, the guidelines recommend that NPs perform routine 
screening for other cancers due to the survivor’s increased risk of second primary cancers. For 
breast cancer survivors, this routine screening should include annual gynecological 
examinations. NPs should especially perform gynecological exams in the postmenopausal 
women receiving selective estrogen receptor modulator (SERMs) therapy (ACS/ASCO, 2016).   
Assessment and Management of Late and Long-Term Effects  
The risk for physical and psychological late and long-term effects is associated with 
several factors. These factors include treatment(s) type, duration and dose, age of the patient, and 
any existing cancer or treatment complications (ASC, 2017). As previously recommended, the 
oncology treatment summary or survivorship care plan can be a helpful tool for NPs when 
assessing and managing these effects; NPs in primary care should request these documents from 
the referring oncologist if not made available. In assessing and managing these effects, the 
ACS/ASCO (2016) offers specific guidelines for management of the most common complaints. 
These effects are as follows:  
Body Image Concerns. ACS/ASCO (2016) recommends that NPs assess patients for 
body image concerns as a result of the breast cancer and subsequent treatments. If physical 
concerns are present, women should be offered adaptive devices (i.e., wigs or prosthetics breast) 
or if appropriate be referred for a surgical consult. Surgical consultations should be considered 
with women who underwent a partial or total mastectomy and opted out of breast reconstruction 
at the time of treatment. If body image concerns persist, NPs should refer these patients for 
psychological care. Such care can offer “support groups, psychotherapy, cognitive behavioral 
therapy, couple-based interventions, or sex therapy” depending on the individual’s needs 
(ACS/ASCO, 2016, p.54). 
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Lymphedema. NPs should counsel breast cancer survivors in the prevention and 
reduction of lymphedema. Such counseling includes healthy weight maintenance, routine 
physical activity of slowly progressive resistance training, and avoiding venipunctures, blood 
pressure or injections on the affected arm. If lymphedema develops and persists, NPs are 
recommended to refer the patient to a physical therapist, occupational therapist, or lymphedema 
specialist for symptom management (ACS/ASCO, 2016).  
Cardiotoxicity. Breast cancer survivors are at increased risk for cardiotoxicity. As such, 
the guidelines recommend NPs routinely monitor cholesterol levels and screen for cardiovascular 
disease. Survivors should be educated about their increased cardiovascular disease risk and be 
instructed in maintaining a heart-healthy lifestyle to help minimize potential effects. Likewise, 
breast cancer survivors should be made aware of pertinent symptoms (i.e., chest pain, shortness 
of breath, or fatigue) that if experienced should be reported to the NP immediately (ACS/ASCO, 
2016).  
Cognitive Impairment. It is recommended that NPs assess for cognitive impairment of 
breast cancer survivors with specific questions to the patient and family member(s). These 
questions should address whether or not the patient subjectively perceives cognitive difficulties. 
Such difficulties can include problems with concentration, memory, and executive function. If 
difficulties exist, guidelines recommend NPs refer the patient for a consultation with a 
neuropsychologist for potential neurocognitive rehabilitation (ACS/ASCO, 2016).  
Distress, Depression, Anxiety. All breast cancer survivors should be assessed for 
symptoms of distress, depression and or anxiety by the NP. Those survivors at high risk for 
depression (i.e., younger women, history of psychiatric disorders, or women with lower 
socioeconomic status) should have a more extensive assessment performed by the NP to 
determine if intervention is necessary. In-office counseling, pharmacotherapy, and mental health 
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referrals should be offered by the NP to survivors experiencing distress, depression, and anxiety 
(ACS/ASCO, 2016). 
Fatigue. Up to 91% of breast cancer survivors experience prolonged fatigue 
(ACS/ASCO, 2016).  It is therefore recommended that NPs assess breast cancer survivors for 
fatigue. As is routine, causative factors should be assessed and treated appropriately. If the 
underlining cause of fatigue is unidentifiable, NPs should encourage routine physical activity and 
other healthy lifestyle modifications (ACS/ASCO, 2016). 
Bone Health. Guidelines recommend a NP obtain a baseline dual-energy X-ray 
absorptiometry (DEXA) for postmenopausal breast cancer survivors. Repeat DEXA scans are 
recommended every two years for women actively taking aromatase inhibitors, and 
premenopausal patients taking tamoxifen or GnRH agonist. Likewise, NPs should refer women 
with chemotherapy-induced premature menopause for repeat DEXA scans every two years 
(ACS/ASCO, 2016). 
Musculoskeletal Health. NPs are encouraged to assess breast cancer survivors for 
musculoskeletal symptoms at each encounter. This patient assessment should include pain, 
weakness, and decreased ROM. Guidelines recommend patient education regarding physical 
activity and appropriate referrals to physical therapy, acupuncture, or rehabilitation (ACS/ASCO, 
2016). 
Pain and Neuropathy. When NPs are assessing pain and its contributing factors, 
ACS/ASCO (2016) recommends the use of the pain scale and comprehensive subjective history. 
Survivors experiencing pain should first be offered NSAIDs, acetaminophen, acupuncture and 
physical activity as interventions for pain relief. If the pain is uncontrolled, NPs should refer the 
patient to the appropriate specialist depending on the determined underlying etiology. Such 
specialists may include physical therapist, occupational therapist, lymphedema specialist, and 
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pain management specialist. Similarly, guidelines dictate that breast cancer survivors should be 
assessed for peripheral neuropathy symptoms through a detailed history and physical. Those with 
neuropathic symptoms (i.e., pain, numbness, and tingling in hands and feet) should be instructed 
by the NP to manage symptoms with physical activity and offer duloxetine as an option 
(ACS/ASCO, 2016). 
Sexual Health and Infertility. The guidelines recommend that NPs assess survivors for 
signs and symptoms of sexual dysfunction or issues with intimacy. The assessment should 
determine contributing factors to the sexual dysfunction.  If contributing factors are reversible, 
they should be addressed by the NP when appropriate. These factors may include vaginal 
dryness, decreased libido, or body image concerns. NPs should offer water-based lubricants, 
vaginal moisturizers, support groups, sexual or marital counseling or intensive psychotherapy, 
when appropriate. If the breast cancer survivor is of childbearing years and experiencing 
infertility, the NP should refer the patient to a reproductive endocrinology specialist as soon as 
possible (ACS/ASCO, 2016). 
Premature Menopause. The guidelines recommend that NPs utilize pharmacotherapy 
and encourage lifestyle modifications in the management of premature menopausal symptoms 
with breast cancer survivors. Recommended pharmacotherapy for vasomotor symptom 
management includes SSRIs, SNRIs, and gabapentin. Lifestyle and environmental modifications 
that may help with symptom management involve rhythmic breathing, exercise, vitamins, cool 
rooms, and avoidance of caffeine, alcohol and spicy foods (ACS/ASCO, 2016). 
Health Promotion 
In addition to cancer surveillance and management of late and long-term side effects, the 
ACS/ASCO Breast Cancer Survivorship Care Guidelines (2016) also provides evidence-based 
health promotion recommendations for breast cancer survivors. Health promotion is key to 
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enhancing the quality and length of life for breast cancer survivors. It consists of healthy 
behaviors that can help reduce secondary cancers, possible recurrence, comorbidities, and 
presences or severity of late or long-term effects. The ACS/ASCO (2016) recognizes that health 
promotion is essential to survivors and provides recommendations to address five health 
promotion domains for NPs and patients to utilize in pursuing best health outcomes. These 
domains include information, obesity, physical activity, nutrition, and smoking cessation 
(ACS/ASCO, 2016).  
Under the “information” recommendation, NPs are advised to assess the patient for 
knowledge gaps related to diagnosis, treatment, side effects, or available resources. NPs should 
provide relevant information to the patient or refer them to appropriate resources to meet their 
informational needs. The “obesity” and “nutrition” recommendations advise that NPs counsel 
breast cancer survivors to help them achieve and maintain a healthy weight. Overweight or obese 
breast cancer survivors should be instructed to consume a low-calorie and balanced diet. The 
“physical activity” recommendation advises that breast cancer survivors engage in regular 
physical activity (i.e., 75 minutes of vigorous aerobic exercise per week). NPs should encourage 
physical activity to include strength training at least two days per week. Strength training should 
be emphasized in women treated with hormone therapy or chemotherapy. This is emphasized in 
these cases to help improve posture, upper body mobility, energy, and muscle endurance, all of 
which may be significantly diminished as a result of systemic treatment (Stefani, Galanti, & 
Klika, 2017). Finally, the “smoking cessation” recommendation strongly advises that breast 
cancer survivors avoid smoking or seek counseling concerning smoking cessation. NPs should 
educate survivors about the increased risk of mortality among those survivors who smoke versus 
those who don’t (ACS/ASCO, 2016).   
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Care Coordination 
To promote care coordination, NP’s are encouraged to establish communication with the 
patient’s oncology team and consult with them to create the survivorship care plan (ACS/ASCO, 
2016). Survivorship care plans provide information to create a smoother transition from 
oncology to primary care for the breast cancer survivor. Survivorship care plans include 
oncology-specific recommendations and pertinent patient and treatment information to help 
guide the NP’s decisions with survivorship care. Additionally, NPs are encouraged to include 
and coordinate with caregivers and other pertinent family members in survivorship care 
(ACS/ASCO, 2016). 
Survivorship Guidelines in Primary Care 
The ACS/ASCO Breast Cancer Survivorship Guidelines were created in response to the 
strong consensus in the literature that NPs have inadequate knowledge of survivorship care 
(Hewitt et al., 2005; Pandey & Barber, 2016; ACS/ASCO, 2016; GWCI, 2013). These guidelines 
are intended to help clinicians efficiently navigate post-cancer care needs of female breast cancer 
survivors. As the breast cancer survivor population continues to rise, so does the need for breast 
cancer survivorship care implementation. As such, NPs must increase their understanding of the 
updated Breast Cancer Survivorship Care Guidelines (Pandey & Barber, 2016; ACS/ASCO, 
2016).  
Although NPs play a significant role in caring for breast cancer survivors, they frequently 
lack necessary training and understanding to care for them properly. As the emerging backbone 
of primary care, NPs have a significant role in assessing, diagnosing, and treating breast cancer 
survivors. This role includes determining if patient complaints are sequelae from previous 
treatment(s) or a result of the diagnosed cancer (Weaver, Jessup, & Mayer, 2013). However, in 
primary care, most NPs have minimal post-cancer care experience or training and need guidance 
 19 
in properly incorporating survivorship care into their practice (Pandey & Barber, 2016). 
Currently, NP education typically includes “one to two didactic hours that cover cancer 
prevention and screening” (Pandey & Barber, 2016, p. 335). This limited overview excludes 
oncology-specific training regarding post-treatment care, provider expectations, and survivorship 
guidelines (ASCO, 2018). Consequently, NPs who are unfamiliar with survivorship care are 
likely to inconsistently screen for primary or secondary cancers, manage late and long-term 
disease, and treat the effects of breast cancer survivors (Pandey & Nguyen, 2017). 
Similarly, inadequately informed NPs are likely to misdiagnose, underdiagnose or over-
diagnosis primary cancer recurrence or development of secondary malignancies (Siu, 2016; 
Pandey & Nguyen, 2017). For example, the U.S. Preventative Services Task Force (USPSTF) 
found that early breast cancer screening (before age 45) in average-risk women results in more 
false-positives than number of deaths averted (Siu, 2016). Inappropriate screening can result in 
unnecessary physical and physiological trauma (i.e., biopsies, distress or anxiety), overuse of 
costly procedures (i.e., PET, CT or bone scans), and unnecessary oncology referrals (Schnipper, 
Smith, Raghavan, Blayney, Ganz, Mulvey, & Wollins, 2012; Siu, 2016). Additionally, 
inappropriate management of late and long-term complications of breast cancer treatment(s) can 
adversely affect the quality of life and long-term health outcomes of breast cancer survivors 
(ACS, 2017; Pandey & Nguyen, 2017).  
Needs Assessment 
Literature brings to light an existing need in primary care for training in cancer 
survivorship care and has suggested continuing education as a potential outlet for enhancing 
survivorship knowledge (Hewitt et al., 2005; Pandey & Barber, 2016; ACS/ASCO, 2016; GWCI, 
2013). However, within the last two years, annual family medicine conferences, such as the 
American Academy of Family Physician’s (AAFP) conference, have not addressed topics 
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concerning cancer survivorship (AAFP, 2017; AAFP, 2018).  
Further, prominent national nurse practitioner conferences during 2017 and 2018 
conference season did not address any topics about cancer survivorship (American Association 
of Nurse Practitioners [AANP], 2017; AANP, 2018). Conversely, oncology-specific conferences 
(i.e., ASCO Annual Conference, NCCN Annual Conference, Annual Survivorship Conference, 
etc.) have offered multiple topics addressing general survivorship care and breast cancer 
survivors for the past two years. This disparity in cancer survivorship content is also seen in 
peer-reviewed journals. For example, the Journal of Clinical Oncology published 227 articles 
about “cancer survivorship” between the years 2006 through 2018. In contrast, the American 
Family Physician generated 11 publications while the Journal of Nurse Practitioners only 
generated two publications addressing cancer survivorship. 
In conjunction with the consistent anecdotal evidence provided in the literature, these 
results further illustrate that cancer survivorship care information is not being adequately 
disseminated to NPs in primary care (Pandey & Barber, 2016). NPs and their patients would 
benefit from an increased understanding of the needs of breast cancer survivors and relevant 
clinical practice guidelines. Thus, it is essential that an intervention be employed to increase 
NPs’ knowledge of the 2016 ACS/ASCO Breast Cancer Survivorship Care Guidelines. This 
DNP project therefore created a professional development project (PDP) based on the current 
ACS/ASCO Breast Cancer Survivorship Care Guidelines for NPs currently working in primary 
care.  
This project created an informative breast cancer survivorship care PowerPoint® 
presentation covering the importance of cancer survivorship, key components of the current 
guidelines, and an explanation of the breast cancer survivorship Toolkit (“Toolkit”). The Toolkit 
includes a Quick Care Guide document and a list of available resources that the provider can 
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access for further information and patient resources. Combined, these project components 
increase the NP’s knowledge of current guidelines and assist them in providing evidence-based 
care.  
Population Identification 
The project deliverables, PowerPoint® and associated Toolkit, were developed with the 
eventual goal of distribution and use in a specific NP population. That population includes 
primary care NPs working in a metropolitan region with over 2.2 million residents (U.S. 
Department of Commerce, 2017). This urban region offers adequate oncology referrals from 
over 20 different oncology-specific clinics and organizations practicing locally. The 
PowerPoint® and Toolkit may be used by primary care NPs in other regions of the U.S. as 
desired. 
Project Stakeholders  
Those NPs who work in designated primary care clinics were key stakeholders for this 
DNP project. Additional stakeholders included the organization's leaders and the providers' 
patients who were female breast cancer survivors. 
Organizational Assessment 	
The PowerPoint® presentation and Toolkit as project deliverables were developed within 
the curriculum of the Doctor of Nursing Practice (DNP) at a metropolitan state university. The 
curriculum and faculty offered appropriate resources and guidance for development, completion, 
and presentation of the deliverables. In the future, the ultimate goal is to implement the Toolkit at 
the chosen sites in a large medical practice group in a southwestern U.S. state. This healthcare 
organization provides primary care services from approximately 36 primary care offices to the 
surrounding patient population.  
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Scope of the Project  
The scope of this project includes the development of an informative evidence-based 
PowerPoint® presentation and Toolkit designed to promote guideline retention and 
implementation with the intention of increasing the NP's awareness of breast cancer survivorship 
needs and current guidelines. 
Mission and Goals 
The mission of this DNP project was to develop a PowerPoint® presentation and Toolkit 
to improve the understanding and resources of primary care NPs who manage female breast 
cancer survivors. At some future point, these tools will be implemented and enhance the breast 
cancer survivors’ health outcomes as a result of the NPs’ improved understanding and 
implementation of the 2016 ACS/ASCO Breast Cancer Survivorship Care Guidelines in primary 
care. The goal of this project was to develop tools to improve awareness of these guidelines 
among primary care NPs.  
 23 
Chapter 3 
Theoretical Underpinnings and Framework 
Nursing Intellectual Capital Theory 
The nursing intellectual capital theory (NICT) is a middle-range nursing theory that 
supports increasing and developing healthcare personnel’s knowledge as a way to improve 
patient and system outcomes. The NICT was originally derived from the intellectual capital 
theory grounded in economics and business (Covell & Sidani, 2013). The intellectual capital 
theory suggests that an increase in organizational stock knowledge at individual and group levels 
leads to an increase in business performance. Similar studies have shown that this theory in 
practice increased healthcare provider and patient knowledge of guidelines, resources, and 
policies, which thereby enhanced the quality of care, decreased organizational costs, and 
improved work environments (Covell & Sidani, 2013; Aiken, Cimiotti, Sloane,…& Neff, 2011; 
Duffield, Diers, O’Brien-Pallas,…& Aisbett, 2011). 
NICT is comprised of two codependent concepts: the nursing human capital concept and 
the nursing structural capital concept. The nursing human capital concept is defined as “the 
theoretical and practical knowledge nurses obtain from academic education, participation in 
continuing professional development activities and specialty training and work experience” 
(Covell & Sidani, 2013, p.70). Nursing structural capital is the structural or organizational 
resources that contain the necessary information to support nursing knowledge and its 
application in the delivery of patient care. These resources include evidence-based practice 
guidelines, care plans, information technology, and other informational resources aimed at 
professional development. As these resources become more available to providers and 
caretakers, so does the opportunity for improved practice and healthcare outcomes (Covell & 
Sidani, 2013). 
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The NICT supports this DNP project because it promotes enhanced patient care by 
focusing on improving provider knowledge (See Figure 1). Structurally, the NICT supports 
knowledge acquisition through the use of organized resources that facilitate increased nursing 
knowledge and clinical application. Covell and Sidani (2013) recommend the use of evidence-
based guidelines as a relevant resource to promote professional development. In accordance with 
this concept, this project uses an informative PowerPoint and Toolkit adapted from the 2016 
ACS/ASCO Breast Cancer Survivorship Care Guidelines to help advance the primary care NP's 
knowledge on survivorship. The Toolkit includes a Quick Care Guide that details key 
information regarding the survivor’s needs and the NPs’ role during care. Combined, these 
components work towards improving the NPs' knowledge of breast cancer survivor’s needs and 
current clinical guidelines through the development of informative resources (Covell & Sidani, 
2013). 
Figure 1. NICT Project Support. 
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Chapter 4 
Project Plan 
Setting 
  The development of the PowerPoint® Presentation and Toolkit occurred within the DNP 
curriculum structure of a metropolitan state university school of nursing under the guidance of a 
project chair and committee. Ultimately the goal is that these deliverables will be, at some future 
point, implemented in three primary care clinics owned by a large for-profit organization in an 
urban community of Southern Nevada.  
  Two of the clinics operate seven days per week while the other operates five days per 
week. Each provider at these clinics treats 20 to 30 patients daily. Two of the clinics serve adult 
patients only while one serves both pediatric and adult patients. While no data is available for the 
number of patients seen at these clinics that are female breast cancer survivors, these clinics 
serve the same patient population as a large local oncology group with two clinics located within 
proximity of the clinics of interest. 
Population of Interest 
  The project deliverables were developed for a population of primary care NPs as 
previously described. This population includes six NPs currently working in primary care who 
provide care for local female breast cancer survivors. These NPs have varying educational levels 
with five having masters degrees and one having a doctoral degree in family nursing practice. 
The NPs’ years of experience in primary care range from 1 to 18 years of practice.  
Measures, Instruments, and Activities 
 Deliverables of this DNP project included an informative PowerPoint® presentation and 
a Toolkit adapted from the 2016 ACS/ASCO Breast Cancer Survivorship Care Guidelines. Both 
parts were designed to help advance the primary care NP's knowledge of survivorship care by 
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promoting guideline retention and implementation. The project presentation was designed to be 
given over a pre-arranged 40-minute meeting with participating NPs, with 20 minutes allotted to 
the PowerPoint® presentation and Toolkit presentation and 20 minutes allotted to group 
discussion and evaluation. This presentation was designed to be presented to the providers during 
the scheduled one-hour lunch break at each clinic individually with lunch provided. The 
PowerPoint® presentation covers pertinent information concerning the importance of breast 
cancer survivorship care, why its implementation is necessary for the primary care setting, the 
primary care NP’s role in survivorship care, current evidence-based guidelines, and the 
presentation of the Toolkit, as further described in Appendix A.  
  The Toolkit incorporated content overview as well as implementation instructions. The 
Toolkit consists of a provider Quick Care guide for breast cancer survivorship. The Quick Care 
guide provided a summary of care to aid the provider in appropriately managing surveillance, 
screening, late and long-term effects, health promotion, and coordination of care for the breast 
cancer survivor.  
Content validity of the developed Toolkit with the PowerPoint® presentation was 
established by six content expert reviewers. The expert reviewers were comprised of three 
primary care NPs and three oncology NPs. The three oncology NPs work in outpatient oncology 
centers in suburban areas in Nevada, Utah, and Tennessee. Their experience ranges from 6 to 20 
years with two NPs holding master’s degrees and one NP holding a doctorate degree. Similarly, 
the three primary care NPs currently work in primary care outpatient clinics in suburban areas in 
Utah and Nevada. Their experience in this setting ranges from 3 to 20 years with two NPs 
holding masters degrees and one NP holding a doctorate degree. As expert reviewers, the varying 
years of experience provided important perspectives and unique feedback on the Toolkit 
deliverables and its usability in the primary care setting.  
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Content validity for the project deliverables was obtained with the use of an 8-item 
questionnaire (See Appendix C). Each expert reviewer was asked to review the Toolkit 
containing both the PowerPoint® presentation and the Quick Care Guide with the use of the 
questionnaire to report feedback via a grading scale and comment section over a 15-day period 
(See Appendix B). Content validity for this scale was ascertained using a 5-point Likert scale. 
Mean expert ratings and content validity ratios (CVR) for each item was calculated to determine 
content validity for the Toolkit and is further detailed in Chapter 5 and in Appendix C. 
Timeline 
  Activities for this DNP project commenced at the beginning of 2018 with the completion 
of chapters 1-4. The DNP project proposal was defended at the University of Nevada, Las Vegas 
(UNLV) during the Summer of 2018. The complete PowerPoint® presentation, Toolkit, project 
evaluation, and write-up was completed by the end of Fall of 2018. All DNP project chapters, 
final submission to DNP advisory committee, and final DNP project defense occurred during 
Spring of 2019. The complete project timeline is outlined in Appendix A.  
Project Tasks and Personnel 
  The personnel for this project was the DNP student. No other personnel was required for 
the creation of this project. The student was responsible for creating the PowerPoint® 
presentation and the Toolkit adapted from the evidence-based guidelines. The tasks for this DNP 
project included developing an introductory PowerPoint® presentation, the Toolkit, and project 
evaluation. 
Resources and Supports 
  Resources needed for the creation and completion of this DNP project included access to 
the 2016 ACS/ASCO Breast Cancer Survivorship Care Guidelines and a computer with an 
updated version of Microsoft Word. Additionally, access to a printer, copier, and paper were 
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needed for assembling hardcopies of the Toolkit and PowerPoint®.   
Risks and Threats 
   Risks and threats to this DNP project centered around potential issues during the 
development process of the presentation and Toolkit. One such risk was potentially not including 
all essential guideline information in the provider's Toolkit. For the Toolkit to be most effective 
and promote provider utilization, it should include all relevant information while being concise 
and easy for the NP to use. In developing the PowerPoint presentation, the risk of not adequately 
conveying the need for change in breast cancer survivorship care could have adversely affected 
the project outcomes. The PowerPoint® presentation needed to have accurately demonstrated the 
present need for change in breast cancer survivorship care to ensure provider buy-in. Lastly, the 
final Toolkit design could have threatened the project outcomes if components were no longer 
user-friendly, clear, and comparable in size to other commonly used primary care tools.   
Evaluation Plan 
 The evaluation plan focused on the development of the project’s Toolkit and 
PowerPoint® presentation. This process consisted of self-reflection questions of the project 
deliverables and any potential barriers to their use in the primary care setting. First, an evaluation 
of how the evidence-based guidelines translated into the Toolkit and PowerPoint® was vital. 
This evaluation helped determine if the materials were clearly representing and explaining the 
information from the guidelines.  
Second, the Toolkit evaluation determined whether all the necessary information was 
included to successfully assist providers with breast cancer survivorship care. The 2016 
ACS/ASCO Breast Cancer Survivorship Care Guidelines contain 26 pages of information and 
recommendations in addressing specific needs of the survivor. While all of this information was 
 29 
relevant, it was essential to determine what information was most important to include in the 
Toolkit and PowerPoint®.  
Third, the project’s theoretical framework and its underpinnings demonstrated support 
upon evaluation of the completed Toolkit and PowerPoint®. Finally, the Toolkit was assessed 
for whether it is concise and realistic enough for utilization in primary care. These tools must 
stay meaningful, be easily updated, and remain practical for use during busy clinic hours.  
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Chapter 5 
Summary of Project Results 
Research and literature have expressed a growing need for improved breast cancer 
survivorship care in the primary care setting (Hewitt et al., 2005; Pandey & Barber, 2016; 
ACS/ASCO, 2016; GWCI, 2013). With an average five-year survival rate of 90%, knowledge 
and utilization of current breast cancer survivorship care guidelines is becoming increasingly 
more relevant as this growing patient population is cared for by more NPs in the primary care 
setting each year. However, primary care NPs’ lack of awareness of the current 2016 
ACS/ASCO Breast Cancer Survivorship Care Guidelines may hinder their ability to provide the 
best evidence-based care for breast cancer survivors (Pandey & Barber, 2016; ACS/ASCO, 
2016; Pandey & Nguyen, 2017). The development and expert review of this informative Toolkit 
containing the PowerPoint® presentation and the Quick Care Guide was in response to this 
identified need for further information and resources of female breast cancer survivorship care 
for NPs in the primary care setting.  
Data Collection 
The development of the Toolkit and content questionnaire was completed in early 
November of 2018. All six expert reviewers were sent an email mid-November with a letter 
detailing further information and instruction for the review process as well as the project 
deliverables of the Quick Care Guide document and PowerPoint® presentation that comprised 
the Toolkit (See Appendix B). Additionally, the email contained a content questionnaire that was 
used by the expert reviewers to report feedback via a 5-point Likert scale and comment section 
(See Appendix C). Expert reviewers were asked to complete and return the content questionnaire 
via email after a 15-day period to review the Toolkit. 
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The content questionnaire was an 8-item document used to aid the expert reviewers in 
critiquing and reporting feedback for both the PowerPoint® presentation and Quick Care Guide. 
Each reviewer was initially asked basic demographic information on years of experience and 
practice specialty. Instructions on the use of the questionnaire’s 5-point Likert scale and 
comment section were provided to clarify proper use. Questionnaire items focused on content 
presence, accuracy, and usability of the Toolkit deliverables. All completed questionnaires were 
returned to the DNP student by each expert reviewer in early December 2018 via email.  
Data Analysis 
Quantitative Data 
Content validity was determined using the reported data from the 5-point Likert scale, 
with 5 indicating “strongly agree” and 1indicating “strongly disagree,” for each item of the 
content questionnaire. First, all items were reviewed to determine if they were essential or non-
essential. Items that were deemed non-essential contained ratings of 3 or below from the expert 
reviewers. Second, the mean and content validity ratio (CVR) was calculated for each item using 
the formula [(E-(N/2)) / (N/2)] with “E” representing the number of experts who rated the item 
as essential and “N” being the total number of expert reviewers (See Appendix C). A CVR of 1 
indicates that all expert reviewers strongly agreed that the item was essential. Data showed that 
all expert reviewers rated items 1, 2, and 4 as essential with a CVR of 1. A CVR of 0.67 was 
calculated for items 3, 5, 6, 7, and 8 indicating that 5 out of 6 expert reviewers found the items 
essential (See Table 1).  
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Table 1 
Content Validity Index Table 
Item Expert 1 Expert 2 Expert 3 Expert 4 Expert 5 Experts 
6 
Mean CVR 
1 5 5 5 5 5 5 5 1 
2 5 5 4 5 5 5 4.83 1 
3 5 2 4 5 4 5 4.17 0.67 
4 5 4 4 4 5 5 4.5 1 
5 5 5 3 5 5 5 4.7 0.67 
6 5 4 4 5 2 5 4.17 0.67 
7 5 3 5 5 4 5 4.5 0.67 
8 5 5 3 5 5 5 4.7 0.67 
Qualitative Data 
In addition to content validity, comments from each item was reviewed to determine 
rating rational and Toolkit observations, concerns, or critiques. Items 1, 2, and 4 asked if the 
Toolkit was complete, accurately identified all elements of care, and if all the information was in 
accordance with current guidelines. All expert reviewers’ feedback agreed that the Toolkit was a 
comprehensive review of breast cancer survivorship care and reflected the current 2016 
ASC/ASCO Breast Cancer Survivorship Care Guidelines. Items 3, 6, and 7 asked if all the 
information presented in the Toolkit was necessary and if the Quick Care Guide was user-
friendly and appropriate for the primary care setting. Based on feedback, all expert reviewers 
agreed that the information in the PowerPoint® presentation was necessary and helpful for 
primary care. However, the majority of feedback for the Quick Care Guide centered around 
minimizing the amount of information provided and possibly cutting it down to a 1-sided 
document. Lastly, items 5 and 8 asked the expert reviewers if the Toolkit could be readily 
incorporated into the primary care setting and if it would improve the management of breast 
cancer survivors. All expert reviewers’ feedback agreed that the Toolkit would be an educational 
and useful resource for NPs in the primary care setting.  
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 Discussion of Project Results 
 Based on the provided feedback from the expert reviewers, the Toolkit provided 
complete, accurate, and current information based on the 2016 ASC/ASCO Breast Cancer 
Survivorship Care Guidelines. As such, these results show that the content of the Toolkit 
deliverables would address this project’s goal of helping to increase the primary care NP’s 
knowledge of current guidelines and assist them in providing evidence-based care for female 
breast cancer survivors. However, the results of the feedback also revealed that the usability and 
size of the Quick Care Guide was not ideal for the primary care setting. While it was reported 
that the PowerPoint® presentation supplied sufficient information for the primary care NP, 4 out 
of the 6 experts agreed that the Quick Care Guide provided too much information as a reference 
document and needed to be edited down. Based on this information, additional adjustments to the 
Quick Care Guide will be to simplify the document to a more concise outline format to help 
improve usability within the primary care setting.  
Future Implication 
The mission of this DNP project was to develop a Toolkit to improve the understanding 
and educational resources of primary care NPs who manage the care of female breast cancer 
survivors. Results from the content questionnaire have demonstrated content validity for the 
PowerPoint® presentation and Quick Care Guide. Furthermore, they revealed the need for 
additional editing of information and formatting changes for the Quick Care Guide. This 
feedback will be used to improve the Toolkit by making it more succinct and appropriate for 
future use in primary care. Additionally, future implications for this project include a pilot 
implementation in three primary care clinics owned by a large for-profit organization in an urban 
community of Southern Nevada. This pilot implementation will include the presentation of the 
revised Toolkit base on the expert feedback. The presentation will be followed by group 
 34 
discussion and evaluation over a pre-arranged 40-minute lunch meeting with participating NPs 
from the primary care clinics. The future implementation of this Toolkit will help in working 
towards enhanced female breast cancer survivors’ health outcomes as a result of the primary care 
NPs’ improved understanding and implementation of the 2016 ACS/ASCO Breast Cancer 
Survivorship Care Guidelines. 
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Appendix A 
Project Timeline 
January 2018  Begin DNP project proposal  
February-April 2018 Completion of chapters 1-3 
May 2018 Completion of chapter 4 
June 2018 Defend DNP project proposal at UNLV 
July-September 2018 Begin development of project PowerPoint® 
presentation and Toolkit content 
October-December 2018 Complete PowerPoint® presentation and 
Toolkit, project evaluation and write-up 
January-March 2019 Complete DNP project chapters and 
submitted to DNP Advisory Committee  
March 2019  Defend DNP project at UNLV 
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Appendix B  
Toolkit Deliverables  
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Appendix C 
Content Questionnaire 
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Content Validity Index Table 
 
 
Item 
 
Expert 1 
 
Expert 2 
 
Expert 3 
 
Expert 4 
 
Expert 5 
 
Experts 6 
 
Mean 
 
CVR 
         
1 5 5 5 5 5 5 5 1 
2 5 5 4 5 5 5 4.83 1 
3 5 2 4 5 4 5 4.17 0.67 
4 5 4 4 4 5 5 4.5 1 
5 5 5 3 5 5 5 4.7 0.67 
6 5 4 4 5 2 5 4.17 0.67 
7 5 3 5 5 4 5 4.5 0.67 
8 5 5 3 5 5 5 4.7 0.67 
 
The content validity index is calculated using the following formula: 
CVR = [(E-(N/2)) / (N/2)] with E representing the number of experts who rated the item as 
essential and N being the total number of experts.  
The mean total of all of the means was 4.56 indicating that all of the questions were essential. 
The calculation is as follows: 
CVR = [(6-(6/2)) / (6/2)] 
CVR = [(6-3) / 3] 
CVR=[3/3] 
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